AcuCort’s drug Zeqmelit® registered as a trademark in the USA
AcuCort AB announces that the company’s drug Zeqmelit® has been registered as a trademark in the USA.The trademark protection is strategically important for the company’s commercialization phase. The USA is both the world's largest individual pharmaceutical market and AcuCort’s most important market. – It is very positive that we have now received trademark protection for our oral film Zeqmelit® with associated applications in the USA. The trademark protection is an important step towards our upcoming commercialization phase in the USA. Furthermore, we look forward to launching